Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men

被引:119
作者
Giuliano, Anna R. [1 ]
Lu, Beibei
Nielson, Carrie M. [2 ]
Flores, Roberto
Papenfuss, Mary R.
Lee, Ji-Hyun
Abrahamsen, Martha
Harris, Robin B. [3 ,4 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Risk Assessment Detect & Intervent Program, MRC CANCONT, Tampa, FL 33612 USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] Arizona Canc Ctr, Tucson, AZ USA
[4] Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA
关键词
D O I
10.1086/591095
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Human papillomavirus (HPV) infections cause disease in men and women, and male-to-female HPV transmission influences the risk of cancer in females. The purpose of the present study was to describe the overall and age-specific incidence and clearance of HPV infections in men. Methods. In a prospective cohort study of 290 men aged 18 -44 years, participants were examined at baseline and every 6 months, with a mean duration of follow-up of 15.5 months. Results. The period prevalence was 52.8% for any, 31.7% for oncogenic, and 30.0% for nononcogenic HPV infection. The 12-month cumulative risk of acquiring a new HPV infection was 29.2%. Incidences of HPV types 6, 11, 16, and 18 were 2.8, 0.5, 4.8, and 0.8 per 1000 person-months, respectively. The median time to clearance of any HPV infection was 5.9 months (95% confidence interval, 5.7 -6.1 months), with comparable times to clearance for oncogenic and nononcogenic infections. Approximately 75% of men tested negative for any HPV 12 months after initial HPV detection. Age was not significantly associated with HPV incidence or duration of infection in men. Conclusion. HPV infection in men was common, with relatively rapid rates of acquisition and clearance.
引用
收藏
页码:827 / 835
页数:9
相关论文
共 30 条
  • [1] AGARWAL SS, 1993, CANCER, V72, P1666, DOI 10.1002/1097-0142(19930901)72:5<1666::AID-CNCR2820720528>3.0.CO
  • [2] 2-M
  • [3] [Anonymous], CANC FACTS FIG 2007
  • [4] Male sexual behavior and human papillomavirus DNA: Key risk factors for cervical cancer in Spain
    Bosch, FX
    Castellsague, X
    Munoz, N
    deSanjose, S
    Ghaffari, AM
    Gonzalez, LC
    Gili, M
    Izarzugaza, I
    Viladiu, P
    Navarro, C
    Vergara, A
    Ascunce, N
    Guerrero, E
    Shah, KV
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (15): : 1060 - 1067
  • [5] BUCKLEY JD, 1981, LANCET, V2, P1010
  • [6] Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.
    Castellsague, X
    Bosch, FX
    Munoz, N
    Meijer, CJLM
    Shah, KV
    de Sanjose, S
    Eluf-Neto, J
    Ngelangel, CA
    Chichareon, S
    Smith, JS
    Herrero, R
    Moreno, V
    Franceschi, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) : 1105 - 1112
  • [7] A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica
    Castle, PE
    Schiffman, M
    Herrero, R
    Hildesheim, A
    Rodriguez, AC
    Bratti, MC
    Sherman, ME
    Wacholder, S
    Tarone, R
    Burk, RD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (11) : 1808 - 1816
  • [8] Carcinogenicity of human papillomaviruses
    Cogliano, V
    Baan, R
    Straif, K
    Grosse, Y
    Secretan, B
    El Ghissassi, F
    [J]. LANCET ONCOLOGY, 2005, 6 (04) : 204 - 204
  • [9] Prevalence of HPV infection among men: A systematic review of the literature
    Dunne, Eileen F.
    Nielson, Carrie M.
    Stone, Katherine M.
    Markowitz, Lauri E.
    Giuliano, Anna R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (08) : 1044 - 1057
  • [10] Reliability of sample collection and laboratory testing for HPV Detection in Men
    Flores, Roberto
    Abalos, Andrew T.
    Nielson, Carrie M.
    Abrahamsen, Martha
    Harris, Robin B.
    Giuliano, Anna R.
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2008, 149 (01) : 136 - 143